ZYLOX-TONBRDG.MED.TECH.H1 (F:818) — Market Cap & Net Worth
Market Cap & Net Worth: ZYLOX-TONBRDG.MED.TECH.H1 (818)
ZYLOX-TONBRDG.MED.TECH.H1 (F:818) has a market capitalization of $708.79 Million (€606.27 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #10590 globally and #1236 in its home market, demonstrating a -21.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZYLOX-TONBRDG.MED.TECH.H1's stock price €1.88 by its total outstanding shares 323428113 (323.43 Million). Also see ZYLOX-TONBRDG.MED.TECH.H1 asset portfolio for a full breakdown of the balance sheet.
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap History: 2021 to 2026
ZYLOX-TONBRDG.MED.TECH.H1's market capitalization history from 2021 to 2026. Data shows change from $967.99 Million to $710.87 Million (-20.17% CAGR). Also see 818 cash flow metrics for how efficiently the company converts equity into cash flow.
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for ZYLOX-TONBRDG.MED.TECH.H1 for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.63x
ZYLOX-TONBRDG.MED.TECH.H1's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.90x
ZYLOX-TONBRDG.MED.TECH.H1's market cap is 4.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $967.99 Million | $177.91 Million | -$199.69 Million | 5.44x | N/A |
| 2022 | $555.84 Million | $334.09 Million | -$113.56 Million | 1.66x | N/A |
| 2023 | $518.03 Million | $527.75 Million | -$78.73 Million | 0.98x | N/A |
| 2024 | $491.56 Million | $782.48 Million | $100.26 Million | 0.63x | 4.90x |
Competitor Companies of 818 by Market Capitalization
Companies near ZYLOX-TONBRDG.MED.TECH.H1 in the global market cap rankings as of September 19, 2026. Review 818 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to ZYLOX-TONBRDG.MED.TECH.H1 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
ZYLOX-TONBRDG.MED.TECH.H1 Historical Marketcap From 2021 to 2026
Between 2021 and today, ZYLOX-TONBRDG.MED.TECH.H1's market cap moved from $967.99 Million to $ 710.87 Million, with a yearly change of -20.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €710.87 Million | -20.34% |
| 2025 | €892.37 Million | +81.54% |
| 2024 | €491.56 Million | -5.11% |
| 2023 | €518.03 Million | -6.80% |
| 2022 | €555.84 Million | -42.58% |
| 2021 | €967.99 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of ZYLOX-TONBRDG.MED.TECH.H1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $708.79 Million USD |
| MoneyControl | $708.79 Million USD |
| MarketWatch | $708.79 Million USD |
| marketcap.company | $708.79 Million USD |
| Reuters | $708.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracrania… Read more